398 related articles for article (PubMed ID: 19796737)
21. Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein IIb/IIIa blockade compared to heparin with routine glycoprotein IIb/IIIa blockade: a REPLACE-2 substudy.
Saw J; Lincoff AM; DeSmet W; Betriu A; Rutsch W; Wilcox RG; Kleiman NS; Wolski K; Topol EJ;
J Am Coll Cardiol; 2004 Sep; 44(6):1194-9. PubMed ID: 15364319
[TBL] [Abstract][Full Text] [Related]
22. Effect of bivalirudin compared with unfractionated heparin plus abciximab on infarct size and myocardial recovery after primary percutaneous coronary intervention: the horizons-AMI CMRI substudy.
Wöhrle J; Merkle N; Kunze M; Cristea E; Mehran R; Rottbauer W; Stone GW
Catheter Cardiovasc Interv; 2012 Jun; 79(7):1083-9. PubMed ID: 22162175
[TBL] [Abstract][Full Text] [Related]
23. Femoral vascular closure device use, bivalirudin anticoagulation, and bleeding after primary angioplasty for STEMI: results from the HORIZONS-AMI trial.
Sanborn TA; Tomey MI; Mehran R; Généreux P; Witzenbichler B; Brener SJ; Kirtane AJ; McAndrew TC; Kornowski R; Dudek D; Nikolsky E; Stone GW
Catheter Cardiovasc Interv; 2015 Feb; 85(3):371-9. PubMed ID: 25179260
[TBL] [Abstract][Full Text] [Related]
24. Early Stent Thrombosis and Mortality After Primary Percutaneous Coronary Intervention in ST-Segment-Elevation Myocardial Infarction: A Patient-Level Analysis of 2 Randomized Trials.
Dangas GD; Schoos MM; Steg PG; Mehran R; Clemmensen P; van 't Hof A; Prats J; Bernstein D; Deliargyris EN; Stone GW
Circ Cardiovasc Interv; 2016 May; 9(5):e003272. PubMed ID: 27165710
[TBL] [Abstract][Full Text] [Related]
25. What anti-thrombotic therapy is best with primary PCI for acute ST elevation myocardial infarction: how should the HORIZONS trial change current practice?
Brodie BR
Catheter Cardiovasc Interv; 2008 May; 71(6):816-21. PubMed ID: 18412079
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of bivalirudin in patients receiving clopidogrel therapy after diagnostic angiography for percutaneous coronary intervention in acute coronary syndromes.
Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
Catheter Cardiovasc Interv; 2010 Oct; 76(4):513-24. PubMed ID: 20882655
[TBL] [Abstract][Full Text] [Related]
27. Frequency and outcomes of provisional glycoprotein IIb/IIIa blockade in patients receiving bivalirudin during percutaneous coronary intervention.
Feldman DN; Wong SC; Bergman G; Minutello RM
J Invasive Cardiol; 2009 Jun; 21(6):258-63. PubMed ID: 19494400
[TBL] [Abstract][Full Text] [Related]
28. Impact of smoking on outcomes of patients with ST-segment elevation myocardial infarction (from the HORIZONS-AMI Trial).
Goto K; Nikolsky E; Lansky AJ; Dangas G; Witzenbichler B; Parise H; Guagliumi G; Kornowski R; Claessen BE; Fahy M; Mehran R; Stone GW
Am J Cardiol; 2011 Nov; 108(10):1387-94. PubMed ID: 21864816
[TBL] [Abstract][Full Text] [Related]
29. The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale.
Mehran R; Brodie B; Cox DA; Grines CL; Rutherford B; Bhatt DL; Dangas G; Feit F; Ohman EM; Parise H; Fahy M; Lansky AJ; Stone GW
Am Heart J; 2008 Jul; 156(1):44-56. PubMed ID: 18585496
[TBL] [Abstract][Full Text] [Related]
30. Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials.
Mehran R; Pocock S; Nikolsky E; Dangas GD; Clayton T; Claessen BE; Caixeta A; Feit F; Manoukian SV; White H; Bertrand M; Ohman EM; Parise H; Lansky AJ; Lincoff AM; Stone GW
JACC Cardiovasc Interv; 2011 Jun; 4(6):654-64. PubMed ID: 21700252
[TBL] [Abstract][Full Text] [Related]
31. MULTInational non-interventional study of patients with ST-segment elevation myocardial infarction treated with PRimary Angioplasty and Concomitant use of upstream antiplatelet therapy with prasugrel or clopidogrel--the European MULTIPRAC Registry.
Clemmensen P; Grieco N; Ince H; Danchin N; Goedicke J; Ramos Y; Schmitt J; Goldstein P;
Eur Heart J Acute Cardiovasc Care; 2015 Jun; 4(3):220-9. PubMed ID: 25182465
[TBL] [Abstract][Full Text] [Related]
32. Comparison of outcomes of patients with ST-segment elevation myocardial infarction with versus without previous coronary artery bypass grafting (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial).
Nikolsky E; Mehran R; Yu J; Witzenbichler B; Brodie BR; Kornowski R; Brener S; Xu K; Dangas GD; Stone GW
Am J Cardiol; 2013 May; 111(10):1377-86. PubMed ID: 23465098
[TBL] [Abstract][Full Text] [Related]
33. Effect of Short Procedural Duration With Bivalirudin on Increased Risk of Acute Stent Thrombosis in Patients With STEMI: A Secondary Analysis of the HORIZONS-AMI Randomized Clinical Trial.
Tamez H; Pinto DS; Kirtane AJ; Litherland C; Yeh RW; Dangas GD; Mehran R; Deliargyris EN; Ortiz G; Gibson CM; Stone GW
JAMA Cardiol; 2017 Jun; 2(6):673-677. PubMed ID: 28249084
[TBL] [Abstract][Full Text] [Related]
34. Impact of anemia on clinical outcomes of patients with ST-segment elevation myocardial infarction in relation to gender and adjunctive antithrombotic therapy (from the HORIZONS-AMI trial).
Tsujita K; Nikolsky E; Lansky AJ; Dangas G; Fahy M; Brodie BR; Dudek D; Möckel M; Ochala A; Mehran R; Stone GW
Am J Cardiol; 2010 May; 105(10):1385-94. PubMed ID: 20451683
[TBL] [Abstract][Full Text] [Related]
35. Effect of switching antithrombin agents for primary angioplasty in acute myocardial infarction: the HORIZONS-SWITCH analysis.
Dangas GD; Mehran R; Nikolsky E; Claessen BE; Lansky AJ; Brodie BR; Witzenbichler B; Guagliumi G; Peruga JZ; Dudek D; Möckel M; Caixeta A; Parise H; White H; Stone GW;
J Am Coll Cardiol; 2011 Jun; 57(23):2309-16. PubMed ID: 21636031
[TBL] [Abstract][Full Text] [Related]
36. Comparison of 600 versus 300-mg Clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary coronary angioplasty.
Mangiacapra F; Muller O; Ntalianis A; Trana C; Heyndrickx GR; Bartunek J; Vanderheyden M; Wijns W; De Bruyne B; Barbato E
Am J Cardiol; 2010 Nov; 106(9):1208-11. PubMed ID: 21029814
[TBL] [Abstract][Full Text] [Related]
37. Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trial.
Généreux P; Mehran R; Palmerini T; Caixeta A; Kirtane AJ; Lansky AJ; Brodie BR; Witzenbichler B; Mockel M; Guagliumi G; Peruga JZ; Dudek D; Fahy MP; Dangas G; Stone GW;
EuroIntervention; 2011 Dec; 7(8):905-16. PubMed ID: 22157475
[TBL] [Abstract][Full Text] [Related]
38. Outcomes in patients with ST-segment elevation acute myocardial infarction treated with clopidogrel versus prasugrel (from the INFUSE-AMI trial).
Brener SJ; Oldroyd KG; Maehara A; El-Omar M; Witzenbichler B; Xu K; Mehran R; Gibson CM; Stone GW
Am J Cardiol; 2014 May; 113(9):1457-60. PubMed ID: 24630789
[TBL] [Abstract][Full Text] [Related]
39. Economic impact of switching to bivalirudin for a primary percutaneous coronary intervention in a US hospital.
Olchanski N; Slawsky KA; Plent S; Kado C; Cyr PL
Hosp Pract (1995); 2010 Nov; 38(4):138-46. PubMed ID: 21068538
[TBL] [Abstract][Full Text] [Related]
40. A randomized trial comparing clopidogrel versus ticlopidine therapy in patients undergoing infarct artery stenting for acute myocardial infarction with abciximab as adjunctive therapy.
Parodi G; Sciagrà R; Migliorini A; Memisha G; Moschi G; Valenti R; Pupi A; Antoniucci D
Am Heart J; 2005 Aug; 150(2):220. PubMed ID: 16086921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
